logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Windlas Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    543329
    INE0H5O01029
    225.6263821
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WINDLAS
    34.98
    2140.09
    EPS(TTM)
    Face Value()
    Div & Yield %:
    29.27
    5
    0.53
     
Yaan Enterprises standalone net profit rises 525.00% in the March 2024 quarter
May 27,2024
Net profit of Yaan Enterprises rose 525.00% to Rs 0.25 crore in the quarter ended March 2024 as against Rs 0.04 crore during the previous quarter ended March 2023. Sales rose 66.09% to Rs 1.91 crore in the quarter ended March 2024 as against Rs 1.15 crore during the previous quarter ended March 2023.

For the full year,net profit rose 716.67% to Rs 0.49 crore in the year ended March 2024 as against Rs 0.06 crore during the previous year ended March 2023. Sales rose 103.27% to Rs 4.98 crore in the year ended March 2024 as against Rs 2.45 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1.911.15 66 4.982.45 103
OPM %17.802.61 -13.863.67 -
PBDT0.350.03 1067 0.700.09 678
PBT0.330.03 1000 0.670.07 857
NP0.250.04 525 0.490.06 717